1. From the Study Coordinating Centre, Hypertension and Cardiovascular Rehabilitation Unit, Department of Molecular and Cardiovascular Research, University of Leuven, Belgium (J.-G.W., J.A.S., R.F.); the Centre for Epidemiological Studies and Clinical Trials (J.-G.W.), Ruijin Hospital, Shanghai Institute of Hypertension, Shanghai, China; the Preventive Cardiology Program, University of California, Irvine (S.S.F.); and the Department of Clinical Pharmacology, Claude Bernard University, Lyon Hospitals,...